Acetylcholinesterase (AChE) is emerging as an important contributor to apoptosis in various cell types. However, overexpression of AChE does not initiate apoptosis, and cells which express AChE at basal levels grow normally, suggesting that AChE may function differently between normal and apoptotic conditions. In this study, we determined that an AChE-derived protein (∼55 kDa) positively correlated with cellular apoptotic levels. The 55 kDa AChE protein was not a result of a novel splice variant of the AChE primary transcript. Instead, it was determined to be a cleaved fragment of the full-length 68 kDa AChE protein that could not be inhibited by cycloheximide (CHX) but could be suppressed by caspase inhibitors in apoptotic PC-12 cells. Furthermore, activation of the Akt cascade abolished the 55 kDa protein, and both AChE protein forms (68 and 55 kDa) accumulated in the nucleus during apoptosis. In a mouse model for ischemia/reperfusion (I/R)-induced acute renal failure, the 55 kDa AChE protein was detected in the impaired organs but not in the normal ones, and its levels correlated with the genotype of the mice. In summary, a 55 kDa AChE protein resulting from the cleavage of 68 kDa AChE is induced during apoptosis, and it is negatively regulated by the Akt pathway. This study suggests that an alternative form of AChE may play a role in apoptosis.
Introduction
Throughout the last century, acetylcholinesterase (AChE; EC 3.1.1.7) has been the focus of extensive research aimed at understanding its role in terminating neurotransmission at cholinergic synapses and neuromuscular junctions (Taylor and Radic, 1994) . In addition to the nervous system, AChE is present in a wide variety of other cellular systems such as epithelial cells, blood cells and vascular endothelial cells (Fujii and Kawashima, 2001; Kirkpatrick et al., 2003) , indicating that the enzyme may be involved in certain 'non-canonical' actions. Several reports have documented the non-canonical functions of AChE that include the regulation of several biological functions, such as neuritogenesis (Grifman et al., 1998) , proliferation (Xiang et al., 2008) , cell adhesion (Darboux et al., 1996; Grifman et al., 1998) , synaptogenesis (Scheiffele et al., 2000) , assembly of amyloid fibers (Inestrosa et al., 1996) , hematopoiesis and thrombopoiesis (Brown et al., 1990; Lev-Lehman et al., 1997) . Although these functions have yet to be clarified, these studies have increasingly added to our knowledge of this enzyme. AChE expression is regulated in a tissue-specific manner. The AChE pre-mRNA transcript is alternatively spliced at the 3 ′ end into three distinct AChE splice variants, thereby generating three different AChE proteins, AChE-S, AChE-R and AChE-E (Li et al., 1991; Karpel et al., 1994; Meshorer et al., 2002) . All three proteins share a common core, but possess distinct C-termini, which endow them with different 'non-canonical functions' that are independent of their acetylcholine (ACh)-hydrolyzing capacities.
Among the three variants, AChE-S was reported to be elevated in response to various apoptotic stimuli Zhang et al., 2002; Ye et al., 2010) . Moreover, suppression of AChE inhibits apoptosome formation and rescues cells from apoptosis (Park et al., 2004) , suggesting the pivotal role of AChE in apoptosis. However, overexpression of AChE increases the sensitivity of cells to apoptotic induction but does not initiate apoptosis (Jin et al., 2004) . Additionally, a variety of cells which express AChE at basal levels grow normally, suggesting that certain differences exist in AChE between normal and apoptotic conditions.
The PI3-kinase (PI3K)/Akt pathway plays an important role in the growth factor signaling cascade (Pettmann and Henderson, 1998) . Previous studies indicate that PI3K primarily mediates its protective effects via its downstream target, Akt (Franke et al., 1997) . In most cases, activation of the Akt cascade requires PI3K activation, since PI3K phosphorylates the phosphatidylinositol protein kinases (PtdIns) which in turn provide an anchoring site for pleckstrin homology (PH) domain-containing proteins such as Akt (Li et al., 2009 ) and its upstream activation factor, PDK1 (Vanhaesebroeck and Alessi, 2000) . Akt delivers an antiapoptotic signal by several mechanisms, including the phosphorylation and inactivation of Bad (Datta et al., 1997) and caspase 9 (Cardone et al., 1998) and by stimulating NF-kB activity via the activation of IKK (Romashkova and Makarov, 1999) . The Akt protein can be phosphorylated by a variety of stimuli, including molecules, such as insulin and nerve growth factor (NGF) as well as those that regulate G-protein-coupled receptors and other activators such as hydrogen peroxide and zinc (Brazil and Hemmings, 2001) . Constitutive activation of the PI3K/Akt pathway has been observed in several human cancers including ovarian (Yuan et al., 2000) , breast (Nakatani et al., 1999) and prostate cancers (Graff et al., 2000) , whereas the inhibition of Akt signaling is known to induce apoptosis in certain human cancer cell lines (O'Gorman et al., 2000; Yuan et al., 2000) .
In the present study, by employing two different cell lines, human umbilical vein endothelial cells (HUVEC) and rat pheochromocytoma cells (PC-12) which express AChE at different basal levels, we identified a 55 kDa AChE protein that positively correlated with the progression of apoptosis. The 55 kDa AChE protein was a cleaved fragment of the full-length (68 kDa) AChE protein, and activation of the Akt cascade inhibited formation of the 55 kDa protein. We further investigated the subcellular localization of both these AChE protein forms during apoptosis and their expressions in a mouse model for ischemia/reperfusion (I/ R)-induced acute renal failure. Our findings support the notion that alternative forms of AChE may play a role in apoptosis.
Results

Increased expression of AChE in apoptotic HUVEC
In order to explore whether there are differences in AChE between normal and apoptotic conditions, HUVEC, which express AChE at basal levels, were used. We first measured the AChE expression level in these endothelial cells in vivo. Frozen sections of normal and apoptotic human umbilical cords (described in the 'Materials and methods' section) were cytochemically stained with hematoxylin and specifically for AChE. Compared with the normal (untreated) cells, AChE enzymatic activity increased drastically in apoptotic vascular endothelial cells in situ ( Figure 1A) . To determine whether this increased enzymatic activity results from the increased AChE expression and to reveal the association between AChE and apoptosis directly at a single cell level, isolated HUVEC that were cultured in complete or serum-deficient medium were double-stained with anti-AChE and anti-cleaved caspase 3 (a biomarker for apoptosis) antibodies. Compared with the normal HUVEC, the serumstarved HUVEC had more intensive AChE staining that correlated with the cleaved caspase 3 staining and condensed nuclei ( Figure 1B) . Meanwhile, the cell lysates of the cultured cells mentioned above were analyzed by immunoblotting with antibodies against AChE, vW Factor (an endothelium lineage marker) or cleaved PARP (a biomarker for apoptosis). AChE expression was relatively low in normal HUVEC and increased remarkably in apoptotic cells ( Figure 1C) . Interestingly, along with the increase in the full-length AChE protein (with a molecular weight of 68 kDa), a 55 kDa band was also detected in the apoptotic cells ( Figure 1C ). Taken together, such an increase in AChE expression in response to apoptotic stimuli in HUVEC was consistent with our previous observations in other cell systems, but here the induction of a 55 kDa band recognized by the AChE antibody caused our concern. Induction of a 55 kDa band during apoptosis
To determine whether the 55 kDa band was specifically induced in apoptosis, immunoblotting with cell extracts obtained from apoptotic cells induced by various treatments was performed. Human microvascular endothelial cells (HMEC-1) were treated with four different toxic agents: A23187 and thapsigargin (TG) (both increase cytosolic calcium concentrations and cause calcium disorder either by allowing ions to cross cell membranes or blocking the ability of the cell to pump calcium into the endoplasmic reticulum), etoposide (inhibits the topoisomerase II, thus causes DNA strands to break) or hydrogen peroxide [activates the reactive oxygen species (ROS)] (Zhu et al., 2007; Park et al., 2008) . After treatment, the cell lysates were analyzed by immunoblotting with antibodies against AChE or cleaved PARP. AChE increased in all cell samples treated with apoptotic agents, but not in the untreated control. Meanwhile, a 55 kDa band was also detected in the corresponding apoptosis-induced samples (Figure 2A ). A similar pattern was observed when cells were exposed to increasing concentrations (100 -400 mM) of hydrogen peroxide ( Figure 2B ). Additionally, we performed a time-course study (0-36 h) with hydrogen peroxide treatment (200 mM), and the results showed that induction of the 68 kDa AChE protein proceeded that of the 55 kDa protein. In addition, expression of both the 68 kDa and 55 kDa bands initially increased up to 24 h and leveled off thereafter. This may be a result of synthesis and degradation rate coming to equilibrium within the cell ( Figure 2C) . These findings demonstrated that in addition to the increased expression of the full-length AChE protein, a 55 kDa band, specifically recognized by the AChE antibody, was induced and it positively correlated to the course of apoptosis. AChE silencing inhibited expression of the 55 kDa band and compromised hydrogen peroxide-induced apoptosis in HMEC-1
To further confirm that this 55 kDa band is an AChE-derived protein and to explore the function of AChE in apoptotic endothelial cells, we specifically down-regulated AChE expression by using specific siRNAs. Two different 25-mer RNA oligonucleotides against the human AChE and a scrambled siRNA as the negative control were designed. HEK293T cells were co-transfected with each siRNA and a plasmid encoding an AChE-GFP fusion protein, and both siRNAs efficiently reduced the expression of the AChE-GFP protein ( Figure 3A) . Subsequently, HMEC-1 transfected with each of the siRNAs were exposed to hydrogen peroxide (200 mM) to induce apoptosis. The 55 kDa band appeared together with the full-length AChE in response to the H 2 O 2 treatment and decreased simultaneously with the 68 kDa AChE band in both AChE siRNA groups ( Figure 3B ). Additionally, both siRNAs attenuated the cleavage of PARP induced by hydrogen peroxide ( Figure 3B ). Meanwhile, cells from each of the above groups were collected and analyzed by flow cytometry. When compared with cells transfected with the scrambled siRNA, those transfected with the AChE siRNAs significantly rescued cells from hydrogen peroxide-mediated cell death ( Figure 3C ). We thus concluded that the 55 kDa band, the appearance of which could be specifically inhibited by AChE siRNA treatment, was indeed the AChE protein and not a non-specific band recognized by the AChE antibody. Moreover, the AChE siRNA treatment rescued HMEC-1 from hydrogen peroxide-induced apoptosis, indicating that AChE is a pivotal component which contributes to the progression of apoptosis in endothelial cells. The 55 kDa AChE protein results from the cleavage of full-length AChE
The observed 55 kDa AChE protein may either have resulted from a novel mRNA splice variant of the AChE mRNA primary To determine the origin of the 55 kDa protein, we used PC-12 cells, which are widely used as a model system for neuronal differentiation and also express AChE at basal levels. As expected, the 55 kDa AChE protein was indeed expressed during apoptosis in these cells ( Figure 4A , lanes 1 and 2). Then, the protein synthesis inhibitor cycloheximide (CHX) was added to the PC-12 cells together with hydrogen peroxide treatment. Slight increase was observed in the 55 kDa protein, whereas the 68 kDa AChE protein band decreased with increasing concentrations of CHX ( Figure 4A , lanes 3-6). In a time-course study, the increase in the 55 kDa AChE protein expression paralleled the decrease in the 68 kDa AChE protein expression, indicating that the 55 kDa AChE protein was a cleaved fragment of the larger protein ( Figure 4B ). As caspases are key regulators and mediators of apoptosis, we next investigated the relationship between activation of caspases and formation of the 55 kDa AChE. Caspase 3 is the major 'executor' caspase. Temporally, activation of caspase 3 occurred before the 55 kDa AChE protein was formed ( Figure 4C ). To determine whether the formation of this 55 kDa fragment was affected by the caspase cascade, we used Z-LEHD-FMK, which blocks caspase 9 (upstream activator of caspase 3), and Z-VAD-FMK, which is a pan caspase inhibitor. With the administration of Z-LEHD-FMK, the intensity of the 55 kDa AChE protein band decreased in a dose-dependent manner ( Figure 4D , lanes 3-5). Meanwhile, with Z-VAD-FMK, the formation of the 55 kDa fragment was suppressed even at low doses ( Figure 4D , lanes 6-8). Taken together, these results indicate that the 55 kDa AChE protein resulted from the cleavage of the 68 kDa AChE protein, and this cleavage process was regulated by several caspase family members. AChE protein is cleaved at the N-terminus
To clarify which region of the AChE protein undergoes cleavage, we employed two antibodies which were raised against peptides mapping at the N-or C-terminus of AChE for immunoblotting of lysates of normal or hydrogen peroxide (100 mM) treated PC-12 cells. The 68 kDa band could be detected by both antibodies, while the 55 kDa band could only be detected with the C-terminal antibody, suggesting that the cleavage site is at the N-terminus of AChE ( Figure 5A ). To confirm this result, we constructed two plasmids encoding the AChE-GFP fusion protein (with the GFP tag fused to the N-or C-terminus of AChE) ( Figure 5B , upper panel). HEK293T cells were transfected with either plasmid for 18 h followed by apoptosis induction with hydrogen peroxide (200 mM) for another 18 h. In addition to the band of AChE-GFP fusion protein (with a molecular weight of 93 kDa), a smaller band with a molecular weight of 80 kDa was detected only in the extracts of the cells transfected with the C-terminal tagged AChE plasmid and exposed to H 2 O 2 by the anti-GFP antibody, but not in the N-terminal tagged or untreated ones ( Figure 5B , lower panel). To confirm the result, HEK293T cells transfected with the C-terminal tagged AChE plasmid were exposed to hydrogen peroxide or not. Their lysates were then subjected to immunoprecipitation with anti-AChE or anti-actin antibodies (used as an iso-specific control), followed by immunoblot analysis with an anti-GFP antibody. The 80 kDa band that correlated to the 55 kDa AChE band appeared in extracts of the hydrogen peroxide-treated cells but not in the untreated sample ( Figure 5C , right panel). Input lysates were probed with either an anti-AChE or anti-GFP antibody, and an 80 kDa band was detected by both antibodies (Figure 5C , left panel). Since we did not detect the relatively small fragment (13 kDa) either endogenously or exogenously, a simple explanation is that it was degraded during apoptosis. Taken together, these results strongly indicated that the N-terminus of the AChE protein was cleaved to form the 55 kDa AChE protein.
Suppression of the 55 kDa AChE via activation of the Akt cascade
The Akt pathway regulates several key proteins essential for cell survival, including transcription factors and regulators of apoptosis such as the Bcl2 family proteins (Tang et al., 2001) . To investigate whether the formation of the 55 kDa AChE protein was regulated by downstream targets of Akt, we transfected PC-12 cells with a plasmid expressing the myr-Akt protein, a truncated and constitutively active form of Akt (Supplementary Figure S2A ). We found that overexpression of myr-Akt could activate the Akt cascade directly and protected cells from hydrogen peroxide-induced apoptosis (Supplementary Figure S2B) . With increasing concentrations of the plasmid, the intensity of the 55 kDa AChE protein decreased, suggesting that Akt negatively regulates the formation of the 55 kDa AChE protein ( Figure 6A) . Activation of the Akt cascade generally requires PI3K activation (Vanhaesebroeck and Alessi, 2000) . However, the PI3K inhibitor wortmannin did not affect the Lysates were analyzed by immunoblotting with an anti-GFP antibody. (C) HEK293T cells transfected with the C-terminally tagged AChE-GFP plasmid were treated with or without hydrogen peroxide, and the lysates were immunoprecipitated with anti-AChE and then analyzed by immunoblotting using an anti-GFP antibody. Anti-actin antibody was used as an iso-specific control. Input lysates were analyzed with either anti-AChE or anti-GFP antibody on the left. inhibitory effect of myr-Akt on the formation of the 55 kDa AChE protein ( Figure 6B) , indicating that activation of the Akt cascade was sufficient to inhibit the 55 kDa AChE protein. We further investigated the relationship between the 55 kDa AChE protein expression and endogenous activation of the PI3K/Akt cascade in PC-12 cells. Treatment with NGF, an agonist of PI3K that results in the activation of the Akt cascade, suppressed the appearance of the 55 kDa AChE protein ( Figure 6C, lane 8) . On the other hand, administration of wortmannin together with hydrogen peroxide brought forward the appearance of the 55 kDa AChE protein to 6 h rather than 10 h compared with the treatment with hydrogen peroxide alone ( Figure 6C, lanes 4, 5 and 9) , indicating that PI3K negatively regulated the formation of the 55 kDa AChE protein. When glutathione (GSH), a hydrogen peroxide antagonist which attenuates the extent of oxidative stress, was added as a control, we did not detect the 55 kDa AChE protein, suggesting an association between the formation of the 55 kDa AChE protein and apoptosis ( Figure 6C, lane 7) . Thus, we concluded that activation of the Akt cascade suppressed formation of the 55 kDa AChE protein, and PI3K promoted this inhibitory effect via activation of the endogenous Akt pathway.
Subcellular localization of the 55 kDa AChE protein
To determine the distribution of AChE during apoptosis, we compared the subcellular localization of AChE under normal and apoptotic conditions. Relatively low basal level of AChE was observed predominantly distributed in the cytoplasm of HMEC-1 cells under normal conditions ( Figure 7A ). When treated with A23187 (4 mM) for 15 h, AChE expression was obviously up-regulated and AChE was well distributed in both the cytoplasm and the nucleus ( Figure 7A) . We then confirmed the result by expressing AChE with a fluorescent protein tag. Similar to the subcellular distribution pattern we observed in HMEC-1 cell endogenously, AChE-GFP (with the GFP fused to the C-terminus) also exhibited a cytoplasmic distribution pattern in normal HEK293T cells and translocated into the nucleus after induction of apoptosis ( Figure 7B) . To investigate the localization of the 55 kDa AChE protein, normal and apoptotic HMEC-1 were collected and subjected to nuclear-cytoplasmic separation followed by immunoblot analysis. Under normal growth conditions, the basal level expression of the 68 kDa AChE was detected only in the cytoplasm, and no 55 kDa AChE could be observed in either fraction. In contrast, when apoptosis was induced, the 68 kDa AChE could be observed in both fractions while the 55 kDa protein was predominantly detected in the nuclear fraction, consistent with the observations of the confocal images. The nuclear and cytoplasmic fractions were identified with antibodies against histone 3 and tubulin, respectively ( Figure 7C) . Thus, in addition to the remarkable increase in expression level, the 68 kDa AChE also translocated from the cytoplasm to the nucleus in response to apoptotic stimuli, and the 55 kDa AChE accumulated in the nucleus during this process. Induction of the 55 kDa AChE in the kidney impaired by I/R
To further examine whether expression of this 55 kDa AChE protein occurs in vivo, we employed the renal I/R injury model which causes acute renal failure and is widely used as an in vivo model for apoptosis. Sprague -Dawley rats were given sham or I/R operations. At 12 or 24 h after surgery, the rats were sacrificed, and their kidneys were harvested. As expected, induction of both AChE proteins (68 and 55 kDa) was accompanied with the progression of apoptosis ( Figure 8A) . To confirm the result, wild-type 129 mice and AChE knock-out (129-Ache tm1Loc /J) heterozygous mice (identified by PCR-based genotyping) ( Figure 8B , upper panel) were also given sham or I/R operations (homozygous were too vulnerable to survive the surgery). After the same surgical procedure, obvious impairment was caused in the I/R-operated kidneys of the wild-type mice as indicated by accumulation of the cleaved PARP, whereas in the counterpart heterozygous mice, the impairment was much more reduced. Correspondingly, induction of both AChE proteins was found to be about half of that in heterozygous mice compared with the wild-type mice ( Figure 8B, lower panel) . These data showed that the 55 kDa protein was also induced in the apoptotic organ in vivo, and its levels correlated with the genotype of the mice.
Discussion
Several reports have shown that AChE expression is increased in various cell types undergoing apoptosis Zhang et al., 2002) , including cells expressing AChE at basal levels (Figures 1 and 2) . Direct inhibition of AChE expression by siRNAs could rescue cells from apoptosis, indicating that AChE plays a pivotal role during apoptosis (Figure 3) . Although overexpression of AChE can increase the sensitivity of cells to apoptosis, it cannot initiate this process (Jin et al., 2004) . In fact, there are a variety of cells which express AChE at basal levels including noncholinergic neurons (Wallace, 1981) and some hematopoietic cells, such as red blood cells and megakaryocytes, which grow normally. Thus, certain differences exist in AChE between normal and apoptotic conditions.
In the present study, by employing two different cell lines (HUVEC and PC-12) which express AChE at different basal levels, we identified a 55 kDa AChE protein which was positively correlated with the progression of apoptosis (Figures 1 and 2) . This 55 kDa AChE protein was temporally expressed after the activation of caspases and was caspase-dependent ( Figure 4C and D). Inhibition of protein synthesis with CHX indicated that the 55 kDa AChE protein resulted from the cleavage of the 68 kDa AChE. As a matter of fact, AChE protein was found to exist in a state of dynamic equilibrium ( Figure 4A) . The expression of the newly synthesized 68 kDa AChE protein increased simultaneously with the formation of the 55 kDa protein (Figure 4A and B) . Although we do not have direct evidence that caspases cleave AChE directly, Park et al. (2008) previously reported on the interaction of AChE with various apoptosome constituents including caspase 9 and caspase 3. Since activation of proteases, especially the caspase cascade, is a vital step in the process of apoptosis, we believed that it would be interesting to further investigate how caspases and the 55 kDa AChE protein are related in regulating apoptosis.
In this study, we also observed a clear relationship between activation of the PI3K/Akt pathway and formation of the 55 kDa AChE protein ( Figure 6 ). PI3K can be activated in a variety of ways including by insulin and NGF, stimuli that regulate G-protein-coupled receptors and other activators such as hydrogen peroxide and zinc (Brazil and Hemmings, 2001) . Active PI3K in turn activates the Akt pathway via its downstream kinase 129-Ache tm1Loc /J heterozygous mice. Lower panel: wild-type 129 mice and 129-Ache tm1Loc /J heterozygous mice were given operations using the same procedure as described above. The 55 kDa AChE protein was induced in the I/R group, and its levels correlated with the genotype of the mice.
cascade. Phosphorylation and maintenance of the phosphorylation status of Akt proteins are known to preserve cell viability (Zhou et al., 2000) . Transfection of cells with myr-Akt could directly activate the Akt cascade (Supplementary Figure S2A) which resulted in the inhibition of the 55 kDa AChE protein and the suppression of apoptosis ( Figure 4A and Supplementary Figure S2B ). This effect could not be compromised by administration of wortmannin which blocked its upstream activation factor, PI3K ( Figure 6B) . On the other hand, administration of NGF, which can activate endogenous PI3K and in turn activate Akt cascade, abolished the appearance of the 55 kDa AChE induced by hydrogen peroxide (Figure 6C) . Meanwhile, wortmannin reduced the peak time of expression of the 55 kDa AChE protein from 10 to 6 h after the induction of apoptosis ( Figure 6C) . Thus, activation of the Akt cascade suppressed formation of the 55 kDa AChE protein, and PI3K promoted this inhibitory effect via activation of the endogenous Akt pathway.
In investigating the subcellular location of the AChE proteins, they displayed an interesting pattern during apoptosis. AChE was found to be distributed in the cytoplasm under normal growth conditions in HMEC-1 and moved to the nucleus with an obvious up-regulation in expression level in response to apoptosis-inducing signals ( Figure 7A ). This translocation pattern of endogenous proteins was further confirmed by exogenous overexpression of an AChE-GFP fusion protein ( Figure 7B) . Although we could not distinguish between the 68 and the 55 kDa AChE proteins in the confocal images, by nuclearcytoplasmic separation analysis we determined that both forms of the protein accumulated in the nucleus during apoptosis ( Figure 7C) . These findings implicate functions for the AChE proteins in apoptosis, perhaps participating in the modulation of nuclear components leading to chromatin condensation and fragmentation. In this respect, it is possible that AChE also possesses activities besides its pivotal role in the hydrolysis of ACh.
Although the contribution of this 55 kDa AChE to apoptosis remains unclear, some studies have proposed possible roles for the protein. Day and Greenfield (2003) reported that an AChE protein fragment, which is homologous to Ab, could induce apoptosis. Greenfield (2005) also demonstrated that a peptide derived from AChE was a pivotal signaling molecule in neurodegeneration. All these reports emphasized the potential biological significance of the cleaved AChE protein. In a mouse model for I/R-induced acute renal failure, the 55 kDa protein was detected in the impaired organs but not in the normal ones, and its levels correlated with the genotype of the mice. This indicated that increased expression of the 55 kDa AChE protein in apoptotic cells is a highly conserved phenomenon that could be observed both in cultured cells and in animal tissues in vivo ( Figure 8A  and B) .
In summary, we have identified an inducible 55 kDa protein derived from AChE, the expression of which positively correlated with the progression of apoptosis. Treatment with CHX inhibited synthesis of the 68 kDa AChE protein but not the 55 kDa one in apoptotic PC-12 cells. Additionally, formation of the 55 kDa protein could be inhibited by caspase inhibitors, indicating that the 55 kDa AChE protein was a cleaved fragment of the 68 kDa AChE protein. Furthermore, activation of the Akt cascade abolished the 55 kDa protein, demonstrating that it is negatively regulated by the Akt pathway. Although the exact function of the 55 kDa AChE protein still remains to be determined, both forms of the AChE proteins accumulated in the nucleus during apoptosis. Our findings support the notion that alternative forms of AChE may play a role in apoptosis. Further identification of the targets of both AChE proteins in apoptotic cells will provide us important information for the role that AChE plays in programmed cell death.
Materials and methods
Reagents and plasmid A23187, TG, etoposide, wortmannin and CHX were purchased from Sigma. Hydrogen peroxide and GSH were purchased from Shanghai CASB Biotechnology Co. NGF was purchased from Promega. Caspase inhibitors z-VAD-FMK and z-LEHD-FMK were purchased from Biovision. MCDB132 medium and the transfection reagent Lipofectamine 2000 were obtained from Invitrogen. The plasmid coding for human S-AChE was a kind gift from Professor Soreq (The Hebrew University of Jerusalem, Israel). The expression vectors pCR3.1 and pCR3.1myr-AktD4-129 were gifts from Dr Randall N. Pittman (School of Medicine, University of Pennsylvania, Philadelphia, PA, USA).
Antibodies
The mouse monoclonal antibody against the C-terminus of the AChE protein (YSKQDRCSDL) was raised as previously described (Su et al., 2008; Ye et al., 2010) . Specificity of the homemade antibody is described in Supplementary Figure S1 . All relevant assays were performed with this antibody unless otherwise mentioned. The goat anti-AChE (N-terminus) antibody (sc-6432) and the mouse anti-vW factor antibody (sc-73267) were purchased from Santa Cruz. The rabbit polyclonal anti-cleaved caspase-3 antibody (#9661), rabbit polyclonal anti-Akt antibody (#9272), rabbit polyclonal anti-cleaved PARP antibody (human specific #9541; rat specific #9545) and rabbit polyclonal antiphosphorylated Akt (Ser473 #9271) antibody were purchased from Cell Signaling Technology. The mouse monoclonal anti-b-actin antibody (A2228) was purchased from Sigma-Aldrich Co.
Cell culture
Fresh umbilical cords and primary HUVEC were kindly provided by Te Liu (International Peace Maternity and Child Care Center, Medical School of Jiao-Tong University, Shanghai, China). HMEC-1 (human microvascular endothelial cells) were obtained from the Shanghai Cell Resource Center, Chinese Academy of Science. HUVEC and HMEC-1 were cultured in complete MCDB131 medium, as recommended by the manufacturer (Invitrogen). Upon reaching confluence, the cells were transferred to fresh gelatin-coated flasks or coverslips and used up to passage 7 for the experiments described in the present report. Stock cultures of the PC-12 cell line (rat adrenal medulla pheochromocytoma) were purchased from the Shanghai Cell Resource Center, Chinese Academy of Science, and grown in RPMI 1640 medium supplemented with 10% fetal bovine serum (FBS). HeLa and HEK293T cells were also purchased from the Shanghai Cell Resource Center, Chinese Academy of Science, and grown in DMEM medium supplemented with 10% FBS.
Induction of apoptosis
Human umbilical cords freshly removed from the obstetric operations were washed three times with pre-warmed PBS to remove the blood cells. The umbilical cords were then sliced into 0.5 cm thick sections and cultured in MCDB131 with or without 10% FBS for 18 h to induce apoptosis. The tissues were then fixed in 4% (w/v) PFA and cut into 10 mm frozen sections for anti-AChE and hematoxylin staining. All cells were cultured in complete medium supplemented with 10% FBS at 378C in a humidified 5% CO 2 /95% air incubator. Apoptosis was induced in the serum-dependent HUVEC by depriving them of serum for 18 h. Apoptosis was induced in HeLa, PC-12 cells and HMEC-1 by treatment with hydrogen peroxide at different concentrations for different time points. CHX, GSH, NGF and wortmannin were added as described in the 'Results' section.
AChE cytochemical staining
The method for enzyme histochemical staining of AChE was originally described by Karnovsky and Roots (1964) . First, the tissues were sectioned by cryoultramicrotomy on glass slides. The slides were then incubated in 15 ml of 0.1 M sodium phosphate (pH 6.0) containing 10 mg of acetylthiocholine iodide, 1 ml of 0.1 M sodium citrate solution, 2 ml of 30 mM copper sulfate solution and 2 ml of 5 mM potassium ferricyanide solution at room temperature for 4-8 h. Thereafter, the slides were incubated in Harris' hematoxylin solution for another 30 sec. The samples were then dehydrated with ethanol and sealed in neutral balsam.
Small interfering RNAs
Stealth RNAi oligonucleotides against human AChE were purchased from Invitrogen. The two sequences that were effective in silencing human AChE were as follows: siRNA1, AAGUCUCC CGCGUUGAUGAGGGCCU and siRNA2, AAGAAGCGGCCAUCGUACA CGUCCA. The siRNAs were transfected into cells by using Lipofectamine 2000 as per the manufacturer's instructions.
Flow cytometry
Cells were harvested, washed twice with PBS and fixed in 70% ethanol at 48C overnight. The cells were then collected by centrifugation and stained by adding propidium iodide (50 mg/ml) and RNase A (200 mg/ml) at 378C for 30 min. The cell cycle of these cells was determined using the BD FACS Calibur (Becton Dickinson), and the cell cycle phases were analyzed using Flowjo software. Fluorescent staining for AChE and cleaved caspase 3
The cells were fixed for 20 min at room temperature with 4% paraformaldehyde solution, followed by incubation in a permeabilization solution (0.1% Triton X-100 in 0.1% sodium citrate) for 15 min on ice and washed thrice with TBST (50 mM Tris-HCl, pH 7.4, 150 mM NaCl and 0.1% Tween). The fixed cells were first incubated with blocking buffer (5.5% normal goat serum in TBST) for 1 h and then with indicated primary antibodies (1:100 dilution in TBST containing 2% BSA) at 48C for 12 h. Following incubation, the cells were washed and incubated with the secondary antibody (1:100 dilution of the rhodamine-conjugated anti-mouse IgG-R; Santa Cruz) at 378C for 60 min in the dark. The labeled cells were then washed, transferred onto glass slides and observed under a fluorescence microscope.
